UPDATE 1-Tesaro's ovarian cancer drug shows benefit in late-stage trial

June 29 (Reuters) - Tesaro Inc said its ovarian

cancer drug met the main goal of prolonging survival in

patients, without the disease worsening, in a late-stage trial,

sending its shares up 84 percent in premarket trading.

Read more